A robust theoretical and experimental drug design strategy to discover new and highly potent urease inhibitors for Helicobacter pylori based on coumarin derivatives
Más información
Fecha de publicación: | 2022 |
Objetivos: | Discovery new urease inhibitors applying a robust and reliable adapted protocol based on computational methodologies that obtain a good correlation between the binding energy and the experimental values |
Instrumento: | FONDECYT |
Año de Inicio/Término: | 2022-2025 |
Financiamiento/Sponsor: | CONICYT |
Rol del Usuario: | DIRECTOR(A) |
DOI: |
11220444 |